[go: up one dir, main page]

DK0701551T3 - 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister - Google Patents

3-(Indol-3-yl)propensyrederivater som NMDA-antagonister

Info

Publication number
DK0701551T3
DK0701551T3 DK94916035.2T DK94916035T DK0701551T3 DK 0701551 T3 DK0701551 T3 DK 0701551T3 DK 94916035 T DK94916035 T DK 94916035T DK 0701551 T3 DK0701551 T3 DK 0701551T3
Authority
DK
Denmark
Prior art keywords
acid derivatives
propenoic acid
indol
hydrogen
represented
Prior art date
Application number
DK94916035.2T
Other languages
Danish (da)
English (en)
Inventor
Bruce M Baron
Boyd L Harrison
Francesco G Salituro
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of DK0701551T3 publication Critical patent/DK0701551T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/10—Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK94916035.2T 1993-05-27 1994-05-02 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister DK0701551T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6836793A 1993-05-27 1993-05-27
US13932393A 1993-10-19 1993-10-19
US19081494A 1994-02-02 1994-02-02

Publications (1)

Publication Number Publication Date
DK0701551T3 true DK0701551T3 (da) 1997-10-20

Family

ID=27371322

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94916035.2T DK0701551T3 (da) 1993-05-27 1994-05-02 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister

Country Status (17)

Country Link
EP (1) EP0701551B1 (zh)
JP (1) JP3334805B2 (zh)
KR (1) KR100314482B1 (zh)
CN (1) CN1051302C (zh)
AT (1) ATE151750T1 (zh)
AU (1) AU681402B2 (zh)
CA (1) CA2161768C (zh)
DE (1) DE69402703T2 (zh)
DK (1) DK0701551T3 (zh)
ES (1) ES2103590T3 (zh)
FI (1) FI955604L (zh)
GR (1) GR3023973T3 (zh)
HU (1) HU216633B (zh)
IL (1) IL109744A (zh)
NO (1) NO306021B1 (zh)
TW (1) TW262467B (zh)
WO (1) WO1994027964A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9304500D0 (en) * 1993-03-05 1993-04-21 Glaxo Spa Heterocyclic compounds
US5563157B1 (en) * 1994-10-31 1999-02-02 Hoecst Marion Roussel Inc Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
BR9712144A (pt) * 1996-09-30 1999-08-31 Hoechst Marion Roussel Inc Novos antagonistas de nmda (d- aspartato de n-metila).
CN101770315B (zh) 2009-01-05 2012-05-23 鸿富锦精密工业（深圳）有限公司 具有滑动控制的触摸电子装置及其滑动控制方法
CN113419009B (zh) * 2021-06-29 2023-02-07 国家烟草质量监督检验中心 一种氟噻虫砜代谢物的液相色谱串联质谱测定方法
CN113419008B (zh) * 2021-06-29 2023-02-07 国家烟草质量监督检验中心 一种氟噻虫砜代谢物的合相色谱串联质谱测定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
EP3660513A4 (en) * 2017-07-25 2021-04-28 Hitachi High-Tech Corporation Automatic analysis device

Also Published As

Publication number Publication date
HU9503367D0 (en) 1996-01-29
FI955604A7 (fi) 1995-11-21
HU216633B (hu) 1999-07-28
NO954769L (no) 1996-01-25
AU6784394A (en) 1994-12-20
FI955604A0 (fi) 1995-11-21
CA2161768A1 (en) 1994-12-08
CA2161768C (en) 1998-08-18
JPH09508615A (ja) 1997-09-02
NO954769D0 (no) 1995-11-24
DE69402703T2 (de) 1997-11-27
IL109744A (en) 1999-06-20
EP0701551A1 (en) 1996-03-20
GR3023973T3 (en) 1997-10-31
AU681402B2 (en) 1997-08-28
KR100314482B1 (ko) 2002-02-28
ATE151750T1 (de) 1997-05-15
TW262467B (zh) 1995-11-11
FI955604L (fi) 1995-11-21
CN1051302C (zh) 2000-04-12
EP0701551B1 (en) 1997-04-16
CN1124484A (zh) 1996-06-12
JP3334805B2 (ja) 2002-10-15
DE69402703D1 (de) 1997-05-22
NO306021B1 (no) 1999-09-06
IL109744A0 (en) 1994-08-26
WO1994027964A1 (en) 1994-12-08
KR960702438A (ko) 1996-04-27
HUT74620A (en) 1997-01-28
ES2103590T3 (es) 1997-09-16

Similar Documents

Publication Publication Date Title
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
MX9504349A (es) Derivados de aroilpiperidina.
NZ514453A (en) Novel sulfonamide compounds and uses thereof
ATE139778T1 (de) Xanthinverbindungen
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
IE811085L (en) Pyridoxine derivatives
AU641952B2 (en) Substituted N-(imidazolyl)alkyl alanine derivatives
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
CA2134077A1 (en) 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy
DK0902018T3 (da) 2-(arylpheny)amino-imidazolinderivater
DK0701551T3 (da) 3-(Indol-3-yl)propensyrederivater som NMDA-antagonister
NO890440L (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
DK0541263T3 (da) 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister
TW336232B (en) Indol-3-yl propenoic acid derivatives for antagonizing NMDA(N-methyl-D-aspartate) and pharmaceutical compositions thereof
EA200101050A1 (ru) Замещенные бензолактамные соединения
NZ291855A (en) Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists
HRP20050617A2 (en) Imidazol derivatives having affinity for alpha 2 receptors activity
YU38498A (sh) Derivati 2-(arilfenil)amino-imidazolina
DE3467297D1 (en) Benzobicyclononane amino derivatives with anticonvulsive properties